| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/27/2004 | US20040100284 Method for detecting PCR product using electrical signal |
| 05/27/2004 | US20040099540 Test strip and electric meter |
| 05/27/2004 | DE10296998T5 Enzymelektrode und Verfahren zum Herstellen derselben An enzyme electrode and method for manufacturing the same |
| 05/27/2004 | DE10253068A1 Analysis of methylation patterns in a genomic DNA comprises amplification of a target DNA by a method that retains the methylation pattern of the template, followed by analysis of the amplification product by mass spectrometry |
| 05/27/2004 | CA2813515A1 T cell receptor display |
| 05/27/2004 | CA2769657A1 Polynucleotides for the amplification and detection of chlamydia trachomatis and neisseria gonorrhoeae |
| 05/27/2004 | CA2757475A1 Compositions and methods for the treatment of natural killer cell related diseases |
| 05/27/2004 | CA2511248A1 Agents and methods for detecting human adenoviruses |
| 05/27/2004 | CA2506574A1 One step real-time rt pcr kits for the universal detection of organisms in industrial products |
| 05/27/2004 | CA2505974A1 Fluorescent proteins and chromoproteins from non-aequorea hydrozoa species and methods for using same |
| 05/27/2004 | CA2505931A1 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 05/27/2004 | CA2505921A1 Diagnosis of sepsis or sirs using biomarker profiles |
| 05/27/2004 | CA2505902A1 Diagnosis of sepsis or sirs using biomarker profiles |
| 05/27/2004 | CA2505895A1 Expression profiling based on histocultures |
| 05/27/2004 | CA2505886A1 Waveguide system for detection of fluorescently labeled nucleic acid sequences |
| 05/27/2004 | CA2505871A1 Methods and compositions for detecting telomerase activity |
| 05/27/2004 | CA2505843A1 Diagnosis of sepsis or sirs using biomarker profiles |
| 05/27/2004 | CA2505785A1 Diagnosis of sepsis or sirs using biomarker profiles |
| 05/27/2004 | CA2505698A1 Polynucleotides for the amplification and detection of chlamydia trachomatis and neisseria gonorrhoeae |
| 05/27/2004 | CA2505546A1 Molecules preferentially associated with effector t cells and methods of their use |
| 05/27/2004 | CA2505472A1 Methods for identifying dna copy number changes |
| 05/27/2004 | CA2505330A1 Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 05/27/2004 | CA2505151A1 Status determination |
| 05/27/2004 | CA2505090A1 Conjugated oligomeric compounds and their use in gene modulation |
| 05/27/2004 | CA2504952A1 Method of identifying and assessing dna euchromatin for detecting disease |
| 05/27/2004 | CA2504929A1 Compositions comprising alternating 2'-modified nucleosides for use in gene modulation |
| 05/27/2004 | CA2504903A1 Method for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | CA2504701A1 Structural motifs and oligomeric compounds and their use in gene modulation |
| 05/27/2004 | CA2504670A1 Combinatorial libraries of monomer domains |
| 05/27/2004 | CA2504607A1 Methods and compositions for treating neurological disorders |
| 05/27/2004 | CA2504605A1 Treatment of chronic lymphocytic leukemia and prostate cancer with microrna mir15 |
| 05/27/2004 | CA2504554A1 2'-substituted oligomeric compounds and compositions for use in gene modulations |
| 05/27/2004 | CA2504042A1 Methods and materials for examining pathways associated with glioblastoma progression |
| 05/27/2004 | CA2503631A1 Microparticle-based methods and systems and applications thereof |
| 05/27/2004 | CA2503626A1 A methodology of estimating the conformation of a protein by proteolysis |
| 05/27/2004 | CA2503621A1 Methods and compositions for diagnosing dysplasia |
| 05/27/2004 | CA2502822A1 High throughput automatic nucleic acid isolation and quantitation methods |
| 05/27/2004 | CA2502490A1 Transgenic ungulates having reduced prion protein activity and uses thereof |
| 05/27/2004 | CA2501983A1 Improved methods for generating multiple rna copies |
| 05/26/2004 | EP1422525A1 Assays for Trichomonas vaginalis |
| 05/26/2004 | EP1422298A2 Detection of hiv-1 by nucleic acid amplification |
| 05/26/2004 | EP1422297A1 Method of testing for bronchial asthma |
| 05/26/2004 | EP1422296A2 Gedap method (genotyping based on diagnostic amplification products) for detecting and/or preventing genotyping errors from amplification products of a polymorphic locus |
| 05/26/2004 | EP1421951A2 Conserved motif of hepatitis C virus E2/NS1 region |
| 05/26/2004 | EP1421391A2 Sodium channel regulators and modulators |
| 05/26/2004 | EP1421390A2 Mammalian diabetes-mediating proteins |
| 05/26/2004 | EP1421387A2 Cellular immunity test with peptides fixed on a solid support |
| 05/26/2004 | EP1421385A1 Genetic construct intracellular monitoring system |
| 05/26/2004 | EP1421384A2 Hprp4s as modifiers of the p53 pathway and methods of use |
| 05/26/2004 | EP1421383A2 Method to identify modulators for human 3-alpha-hydroxysteroid dehydrogenase |
| 05/26/2004 | EP1421377A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 05/26/2004 | EP1421371A1 Biosensor |
| 05/26/2004 | EP1421370A1 Self-powered biosensor |
| 05/26/2004 | EP1421222A2 Cell culture system for synthesis of infectious hepatitis c virus |
| 05/26/2004 | EP1421221A2 Methods for diagnosing and treating neoplasias using nf-at transcription factors |
| 05/26/2004 | EP1421220A2 Method and nucleic acids for the analysis of colon cancer |
| 05/26/2004 | EP1421219A2 Use of associations between at least one nucleic sequence polymorphism of the sh2 gene and at least one seed quality characteristic in plant selection methods |
| 05/26/2004 | EP1421218A2 Model of autoimmune disease and methods for identifying agents against autoimmune disease |
| 05/26/2004 | EP1421217A2 Surface for the immobilisation of nucleic acids |
| 05/26/2004 | EP1421216A1 Method for manufacturing hydrogel biochip by using star-like polyethylene glycol derivative having epoxy group |
| 05/26/2004 | EP1421215A2 Methods for evaluating pathologic conditions using extracellular rna |
| 05/26/2004 | EP1421214A2 Amplified oncogenes and their involvement in cancer |
| 05/26/2004 | EP1421213A2 Labeled nucleoside polyphosphates |
| 05/26/2004 | EP1421211A2 Methods for detecting dna originating from different individuals |
| 05/26/2004 | EP1421210A2 Method of detecting protease activity in a cell |
| 05/26/2004 | EP1421207A2 Method for the detection of cytochrome b mutations in fungi |
| 05/26/2004 | EP1421206A2 Improved method for measuring membrane potential |
| 05/26/2004 | EP1421205A2 Complexity management of genomic dna |
| 05/26/2004 | EP1421203A2 Novel antigen binding molecules for therapeutic, diagnostic, prophylactic, enzymatic, industrial, and agricultural applications, and methods for generating and screening thereof |
| 05/26/2004 | EP1421201A2 Methods for immobilizing molecules to a solid phase and uses thereof |
| 05/26/2004 | EP1421200A2 Fluorescent multiplex hpv pcr assays using multiple fluorophores |
| 05/26/2004 | EP1421198A2 Cell-based high-throughput screening methods |
| 05/26/2004 | EP1421193A2 Novel metabolism-associated gene products of ashbya gossypii |
| 05/26/2004 | EP1421176A2 Nucleic acids and encoded polypeptides associated with bipolar disorder |
| 05/26/2004 | EP1421175A2 Polymer stabilized proteinases |
| 05/26/2004 | EP1421174A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 05/26/2004 | EP1421111A2 Proteins associated with cell growth differentiation, and death |
| 05/26/2004 | EP1421110A2 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton |
| 05/26/2004 | EP1421101A2 P-glycoproteins and uses thereof |
| 05/26/2004 | EP1421098A2 Surface proteins of streptococcus pyogenes |
| 05/26/2004 | EP1421095A1 Assay for detection of human parvovirus b19 nucleic acid |
| 05/26/2004 | EP1420814A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/26/2004 | EP1420813A1 Pregnancy-related enzyme activity |
| 05/26/2004 | EP1420800A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at 4) receptor activity |
| 05/26/2004 | EP1420745A2 Use of r-nsaid compounds for anti-hiv treatment |
| 05/26/2004 | EP1420636A2 Mycoplasma bovis challenge model, methods for administering m. bovis and methods for inducing pneumonic lung lesions |
| 05/26/2004 | EP1420631A1 Plant-derived resistance gene |
| 05/26/2004 | EP1322339A4 Method for early prediction of the onset of invasive cancer |
| 05/26/2004 | EP1230382B1 Monitoring the activity of factor xa inhibitors |
| 05/26/2004 | EP1159444B1 Membrane module for testing active substances at cells |
| 05/26/2004 | EP1104475B1 C-myc is activated by beta-catenin and tcf-4 |
| 05/26/2004 | EP1088106B1 Polymerase signaling assay |
| 05/26/2004 | EP1083927B1 HUMAN MINOR VAULT PROTEIN p193 |
| 05/26/2004 | EP1030931A4 Uric acid assay device with stabilized uricase reagent composition |
| 05/26/2004 | EP0983498B1 A system for cell-based screening |
| 05/26/2004 | EP0915964B1 Method for quantitation of microorganism contamination of liquids and apparatus therefor |
| 05/26/2004 | EP0905517B1 Analytical method, kit, and apparatus |
| 05/26/2004 | EP0894129B1 Short external guide sequences |
| 05/26/2004 | EP0804454B1 HYBRIDIZATION AND FOOTPRINTING METHODS TO CHARACTERIZE THE INTERACTIONS OF 16S rRNA ANALOGUES FOR IDENTIFICATION OF NOVEL ANTIBIOTICS |
| 05/26/2004 | EP0728217B1 Nucleic acid mutation detection by analysis of sputum |